Editorial
 NEW PATH LAB RULES WEAK   
 Wednesday, October 10, 2018 
 Regulating pathology labs in the country has run into a serious mess now with the notification of the Clinical Establishments Amendment Rules from May 18, 2018 by the Union health ministry. 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Bristol-Myers Squibb's phase 3 CheckMate-331 study does not meet primary endpont
17:20  [IST]Dr Reddy's Laboratories announces sale of its API manufacturing unit in Jeedimetla
17:00  [IST]Bayer's Xarelto receives US FDA nod to treat coronary artery disease
16:10  [IST]Lupin gets US FDA tentative approval for generic lurasidone hydrochloride tablets
16:00  [IST]Pharmaxis announces positive results from phase 1 trial for LOXL2 inhibitor compound to treat fibrotic diseases
15:50  [IST]AiMeD, Busan Technopark ink MoU to boost Indian, Korean medical devices sector
more news >>
TOP NEWS
08:00  [IST]Global pharma cos to shell out more to export products to India as govt raises site registration, inspection fees steeply
08:00  [IST]Domestic syringe cos to hold talks with NLEM panel to check overcharging patients
08:00  [IST]Health ministry planning to implement national tribal health policy
08:00  [IST]Centre accredits RingMD to build telemedicine base in India for affordable healthcare
08:00  [IST]IICT signs MoU with US based NDT for developing side effect free cancer drug in 5 years
08:00  [IST]UP govt in talks with pharmaceutical majors to speed up industry park project in state
more news >>
YESTERDAY'S NEWS
18:00  [IST]Theravance Biopharma, Mylan present positive data from multiple studies of Yupelri at 2018 CHEST meeting
17:00  [IST]Pylote, Amcor join hand to provide innovative packaging solutions for liquid pharmaceuticals
16:00  [IST]Chugai releases disease awareness anime about RA in multiple languages
15:00  [IST]Debiopharm, PSI collaborate to develop novel targeted radiotherapeutic product in oncology
14:00  [IST]SpineEX receives US FDA approval for Sagittae lateral lumbar interbody fusion device
17:10  [IST]Medanta-AyurVAID launched to integrate modern medicine and Ayurveda
more news >>
INTERVIEW  
Rising burden of NCDs impacts Indian healthcare scene
Gagan Singh Bedi, managing director, AstraZeneca Pharma India Gagan-Singh-Bedi.jpg
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the central govt's decision to replace MCI with National Medical Commission boost the medical education scenario in the country?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
ipc_2018
cphi-india_Banner-150x60
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |